Improved Erythrocyte Deformability Induced by Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetic Patients

被引：0
|
作者：
Minkook Son
Ye Sung Lee
A Ram Hong
Jee Hee Yoon
Hee Kyung Kim
Ho-Cheol Kang
Sung Yang
机构：
[1] Gwangju Institute of Science and Technology,Department of Biomedical Science and Engineering, School of Mechanical Engineering
[2] Gwangju Institute of Science and Technology,School of Mechanical Engineering
[3] Chonnam National University Medical School,Department of Internal Medicine
来源：
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词：
SGLT-2 inhibitor; DPP-4 inhibitor; Hemorheology; Blood viscosity; Deformability; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 67
页数：8
相关论文
共 50 条
  • [31] The role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patients
    Ibernon, Meritxell
    Navarro, Maru
    Goma, Montserrat
    Tango, Ariel
    Rap, Oana
    Cabrera, Cristina
    Sanchez, Ana
    Rodriguez, Neus
    Ruiz, Pilar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1768 - I1771
  • [32] The role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patients
    Ibernon, Meritxell
    Navarro, Maru
    Goma, Montserrat
    Tango, Ariel
    Rap, Oana
    Cabrera, Cristina
    Sanchez, Ana
    Rodriguez, Neus
    Ruiz, Pilar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [33] Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus
    Kambara, Takahiro
    Shibata, Rei
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (01) : 108 - 114
  • [34] Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes
    Trujillo, Jennifer M.
    Nuffer, Wesley A.
    PHARMACOTHERAPY, 2017, 37 (04): : 481 - 491
  • [35] Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes
    Fu, Edouard
    D'Andrea, Elvira
    Wexler, Deborah J.
    Patorno, Elisabetta
    Paik, Julie M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 673 - 673
  • [36] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [37] Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis
    Hamblin, Peter S.
    Wong, Rosemary
    Bach, Leon A.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (02)
  • [38] Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
    Scheen, Andre J.
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (10) : 556 - 577
  • [39] Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis
    Hamblin, Peter S.
    Wong, Rosemary
    Bach, Leon A.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (07) : 294 - +
  • [40] Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Vivian, Eva
    DIABETES EDUCATOR, 2015, 41 : 5S - 18S
12345